Biotech ETFs Pop Amid Pending J&J Vaccine Approval

Biotech ETFs are climbing Wednesday as the Food and Drug Administration’s staff endorsed Johnson & Johnson’s coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U.S. marketplace. The staff report released Wednesday is a preliminary step designed to prepare...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.